miR‑512‑5p suppresses the progression of non‑small cell lung cancer by targeting β‑catenin
Open Access
- 14 November 2019
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 19 (1) , 415-423
Abstract
The oncogenic protein β‑catenin is regulated by microRNAs (miRs) in non‑small cell lung cancer (NSCLC). miR‑512‑5p is downregulated in NSCLC compared with healthy tissues and exhibits a tumour‑suppressive effect. To study whether miR‑512‑5p acts on β‑catenin to exert its anticancer effect in NSCLC, miR‑512‑5p mimic and inhibitor were transfected into NSCLC A549 and H1975 cells. miR‑512‑5p mimic inhibited the invasion of NSCLC cells and increased apoptosis, which suggested an inhibitory effect of miR‑512‑5p in NSCLC progression in vitro. By contrast, transfection with the miR‑512‑5p inhibitor resulted in the opposite effects. A dual‑luciferase assay demonstrated that miR‑512‑5p complementarily bound to the 3'‑untranslated region of β‑catenin. miR‑512‑5p mimic suppressed the transcription and translation of β‑catenin and reduced the expression of the downstream oncogenes cyclin D1 and matrix metalloproteinases, leading to the inhibition of Wnt/β‑catenin signalling and subsequent inhibition of NSCLC tumourigenesis in vitro. In conclusion, miR‑512‑5p may function as a tumour suppressor in NSCLC by inhibiting the Wnt/β‑catenin pathway.Keywords
This publication has 29 references indexed in Scilit:
- Wnt Signaling Pathway in Non-Small Cell Lung CancerJNCI: Journal of the National Cancer Institute, 2013
- Down-Regulation of miR-129-5p Inhibits Growth and Induces Apoptosis in Laryngeal Squamous Cell Carcinoma by Targeting APCPLOS ONE, 2013
- MicroRNAs in Head and Neck CancerInternational Journal of Dentistry, 2013
- Predictors of Death, Local Recurrence, and Distant Metastasis in Completely Resected Pathological Stage-I Non–Small-Cell Lung CancerJournal of Thoracic Oncology, 2012
- Time Trends of Overall Survival and Survival after Recurrence in Completely Resected Stage I Non-small Cell Lung CancerJournal of Thoracic Oncology, 2012
- Aberrant Wnt1/β-Catenin Expression is an Independent Poor Prognostic Marker of Non-small Cell Lung Cancer After SurgeryJournal of Thoracic Oncology, 2011
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- Molecular markers and pathogenically targeted therapy in non-small cell lung cancerFrontiers of Medicine in China, 2009
- The canonical Wnt signalling pathway and its APC partner in colon cancer developmentGut, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001